Indefinite Delivery Contract VA24217D0012
Award Date 11/16/16
Last Date to Order 12/18/18
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Diasorin Inc., a Minnesota-based subsidiary of Italian-owned Diasorin S.P.A., has been awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs Veterans Integrated Service Network 15 (VISN 15) with a ceiling value of $730,616.95 and a performance period extending through January 4, 2031. The contract supports chemiluminescence analyzer services and associated supplies for tuberculosis and infectious disease diagnostics at the Kansas City and Columbia Veterans...
- Diasorin Inc., a Minnesota-based medical diagnostics subsidiary of Italian parent company Diasorin S.P.A., was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency valued at $540,000 with an ultimate completion date of September 30, 2030. The contract, which commenced on October 1, 2025, covers LIAISON XL test kits, supplies, and analyzer services without socioeconomic set-aside designation. The LIAISON XL platform represents a chemiluminescence immunoassay analyzer...
- Roche Diagnostics Corporation has been awarded a single award blanket purchase agreement by the Defense Health Agency to provide laboratory testing reagents and a cell stainer. The potential value of the BPA is $129,021.70 through April 2024. A firm fixed price call was placed against the BPA for $15,314.77 to supply reagents supporting DHA programs. The reagents will be delivered to a facility in Castleton, Indiana with performance through September 2023. As the prime contractor, Roche...
- Roche Diagnostics Corporation has been awarded an indefinite delivery contract by the Department of the Army Medical Command to provide immunochemistry testing services. The single award contract has a potential value of $16.6M and period of performance through September 2023. Under the contract vehicle, Roche has received multiple delivery orders to conduct clinical chemistry and immunoassay testing at its facility in Castleton, Indiana for various Army medical treatment facilities. Orders have...
- The Air Force Materiel Command established a Blanket Purchase Agreement with Diasorin Inc. on March 22, 2021, with a $250,000 ceiling for automated instrument chemiluminescence immunoassay (CLIA) testing, diagnostic test kits, and reagents. The BPA remains active through June 30, 2026. Work is performed at Wright-Patterson Air Force Base, Ohio, and Stillwater, Minnesota. The agreement procures Diasorin's LIAISON analyzer platforms, chemiluminescence immunoassay reagents, test kits, and...
- The Defense Health Agency awarded a single-award Blanket Purchase Agreement valued at $37 million to Roche Diagnostics Corporation, effective December 1, 2024, through November 30, 2029. This BPA establishes pre-negotiated pricing and terms for the procurement of immunology and clinical testing reagents, kits, and consumables, including specialized diagnostics for Chlamydia trachomatis and Neisseria gonorrhoeae detection. Roche Diagnostics Corporation, a foreign-owned manufacturer...
- The Defense Health Agency awarded a single-award Blanket Purchase Agreement valued at $606,000 to Roche Diagnostics Corporation for the provision of chemistry analyzers and reagents on a cost-per-reportable-result pricing basis. The contract, effective October 1, 2025, through March 31, 2027, was awarded without set-aside designation, indicating open competition. Performance will be conducted at Roche's facility in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer...
- Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a single-award Blanket Purchase Agreement valued at $10.0 million by the Office of Logistics and Acquisition Operations, a civilian federal agency, with an ultimate completion date of October 31, 2026. This non-competitive IDV establishes a framework for the procurement of operations and maintenance items exclusively, including biological materials, laboratory...
- The Defense Health Agency established a single-award indefinite delivery contract valued at $732.6K with Diasorin Deutschland GMBH, a Germany-based manufacturer of in-vitro diagnostic products, effective September 5, 2023, through September 4, 2028. This indefinite delivery vehicle procures medical testing supplies and laboratory equipment to support Landstuhl Regional Medical Center (LRMC), a major United States military medical facility located in Germany. The contract specifically covers...
- Bio-Rad Laboratories Inc. was awarded a single-award Indefinite Delivery Contract valued at $6.7 million by the Defense Health Agency with an ultimate completion date of September 29, 2025. The contract, awarded on September 30, 2020, establishes a framework for the procurement of reagents, consumables, and serological automated analyzers designed to support military medical operations and warfighter readiness. The primary focus of this Indefinite Delivery Contract is to provide flexible...
- VA24217D0012Indefinite Delivery Contract
- 5Federal Contract Awards
RHEUMATOID ARTHRITIS DISEASE ACTIVITY TESTING
Posted 11/10/16
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $0 | 12/18/17 | |
| Not listed | Not listed | $156.7k | 11/10/16 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order VA24217D0012-36C24220F0152 | Crescendo Bioscience, Inc. | $4.0k | 12/19/19 | 9/30/22 | 6/23/22 | |
Delivery Order VA24217D0012-0002 | Crescendo Bioscience, Inc. | $16.1k | 12/19/17 | 9/30/20 | 2/24/20 | |
Delivery Order VA24217D0012-36C24221F0105 | Crescendo Bioscience, Inc. | $2.3k | 12/19/20 | 9/30/22 | 7/26/22 | |
Delivery Order VA24217D0012-0001 | Crescendo Bioscience, Inc. | $452.2k | 12/19/16 | 10/31/18 | 10/2/18 | |
Delivery Order VA24217D0012-36C24219F0148 | Crescendo Bioscience, Inc. | $8.6k | 12/19/18 | 9/30/20 | 2/24/20 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
632-17-1-107-0001 Rheumatoid Arthritis Disease Activity Testing | VA24217Q0004 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Award Notice 1/1 | 10/4/16, 8:28 AM |